Asthma therapy: basic mechanisms.
D000305:Adrenal Cortex Hormones / Q000494:pharmacology; D000318:Adrenergic beta-Agonists / Q000494:pharmacology; D000818:Animals; D017302:Annexins; D001249:Asthma / Q000188:drug therapy*; D002118:Calcium / Q000378:metabolism; D002199:Capillary Permeability / Q000187:drug effects; D002395:Catecholamines / Q000378:metabolism; D004205:Cromolyn Sodium / Q000494:pharmacology; D006023:Glycoproteins / Q000378:metabolism; D006801:Humans; D007665:Ketotifen / Q000494:pharmacology; D008407:Mast Cells / Q000187:drug effects; D010276:Parasympatholytics / Q000494:pharmacology; D010726:Phosphodiesterase Inhibitors; D011448:Prostaglandin Antagonists; D011943:Receptors, Adrenergic, beta / Q000187:drug effects; D011956:Receptors, Cell Surface / Q000187:drug effects; D011983:Receptors, Purinergic; D012018:Reflex / Q000187:drug effects; D012130:Respiratory Hypersensitivity / Q000188:drug therapy; D012137:Respiratory System / Q000294:innervation; D013806:Theophylline / Q000494:pharmacology
D000305:Adrenal Cortex Hormones; D000318:Adrenergic beta-Agonists; D017302:Annexins; D002395:Catecholamines; D006023:Glycoproteins; D010276:Parasympatholytics; D010726:Phosphodiesterase Inhibitors; D011448:Prostaglandin Antagonists; D011943:Receptors, Adrenergic, beta; D011956:Receptors, Cell Surface; D011983:Receptors, Purinergic; D013806:Theophylline; D004205:Cromolyn Sodium; D002118:Calcium; D007665:Ketotifen